Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Cancer Cell|May 13, 2020
Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune ResponseWendy Béguelin, Matt Teater, Cem Meydan, et al.
Investigational New Drugs|May 9, 2019
A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesotheliomaEmilie M J van Brummelen, Evgeny Levchenko, Manuel Dómine, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 25, 2017
A First-Time-in-Human Study of GSK2636771, a Phosphoinositide 3 Kinase Beta-Selective Inhibitor, in Patients with Advanced Solid TumorsJoaquin Mateo, Gopinath Ganji, Charlotte Lemech, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|February 26, 2008
Are family factors universally related to metabolic outcomes in adolescents with Type 1 diabetes?F J Cameron, T C Skinner, C E de Beaufort, et al.
Cell|July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory FateLeandro Venturutti, Matt Teater, Andrew Zhai, et al.
Nature|December 10, 2020
Histone H1 loss drives lymphoma by disrupting 3D chromatin architectureNevin Yusufova, Andreas Kloetgen, Matt Teater, et al.
Cancer Research Communications|August 18, 2023
Activating Inducible T-cell Costimulator Yields Antitumor Activity Alone and in Combination with Anti-PD-1 Checkpoint BlockadeSapna Yadavilli, Jeremy D Waight, Sara Brett, et al.
Pageof 22